Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Allen

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Nuclear Medicine and Biology|May 8, 2024
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcomaSabeena Giri, Kevin J H Allen, Chandra Bose Prabaharan, et al.
Physics in Medicine and Biology|September 16, 2025
Assessment of the impact of the nuclear properties of<i>β</i><sup>-</sup>-emitting radionuclides on the dosimetry of two radiopharmaceuticals with distinct pharmacokineticsLaura De Nardo, Samuele De Zan, Kevin J H Allen, et al.
Pharmaceutics|July 21, 2019
Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177LutetiumKevin J H Allen, Rubin Jiao, Mackenzie E Malo, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 1986
The evaluation of multiple sclerosis by magnetic resonance imagingV M Runge, A C Price, H S Kirshner, et al.
AJR. American Journal of Roentgenology|November 1, 1984
Magnetic resonance imaging of multiple sclerosis: a study of pulse-technique efficacyV M Runge, A C Price, H S Kirshner, et al.
Access Microbiology|January 8, 2024
Radioimmunotherapy as a pathogen-agnostic treatment method for opportunistic mucormycosis infectionsJorge L C Carvalho, Mackenzie E Malo, Kevin J H Allen, et al.
Oncotarget|October 16, 2020
Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapyWojciech Dawicki, Kevin J H Allen, Ravendra Garg, et al.
Molecules (Basel, Switzerland)|August 14, 2020
Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal InfectionsMuath Helal, Kevin J H Allen, Hilary Burgess, et al.
Southern Medical Journal|July 1, 1980
Diagnostic imaging in pediatric emergenciesR M Heller, C M Coulam, J H Allen, et al.
Cancers|June 2, 2021
Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human OsteosarcomaJaline Broqueza, Chandra B Prabaharan, Samitha Andrahennadi, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Nuclear Medicine and Biology|May 8, 2024
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcomaSabeena Giri, Kevin J H Allen, Chandra Bose Prabaharan, et al.
Physics in Medicine and Biology|September 16, 2025
Assessment of the impact of the nuclear properties of<i>β</i><sup>-</sup>-emitting radionuclides on the dosimetry of two radiopharmaceuticals with distinct pharmacokineticsLaura De Nardo, Samuele De Zan, Kevin J H Allen, et al.
Pharmaceutics|July 21, 2019
Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177LutetiumKevin J H Allen, Rubin Jiao, Mackenzie E Malo, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 1986
The evaluation of multiple sclerosis by magnetic resonance imagingV M Runge, A C Price, H S Kirshner, et al.
AJR. American Journal of Roentgenology|November 1, 1984
Magnetic resonance imaging of multiple sclerosis: a study of pulse-technique efficacyV M Runge, A C Price, H S Kirshner, et al.
Access Microbiology|January 8, 2024
Radioimmunotherapy as a pathogen-agnostic treatment method for opportunistic mucormycosis infectionsJorge L C Carvalho, Mackenzie E Malo, Kevin J H Allen, et al.
Oncotarget|October 16, 2020
Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapyWojciech Dawicki, Kevin J H Allen, Ravendra Garg, et al.
Molecules (Basel, Switzerland)|August 14, 2020
Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal InfectionsMuath Helal, Kevin J H Allen, Hilary Burgess, et al.
Southern Medical Journal|July 1, 1980
Diagnostic imaging in pediatric emergenciesR M Heller, C M Coulam, J H Allen, et al.
Cancers|June 2, 2021
Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human OsteosarcomaJaline Broqueza, Chandra B Prabaharan, Samitha Andrahennadi, et al.
Pageof 11